News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
610,667 Results
Type
Article (43422)
Company Profile (397)
Press Release (566848)
Section
Business (170469)
Career Advice (2533)
Deals (30140)
Drug Delivery (100)
Drug Development (77571)
Employer Resources (170)
FDA (15786)
Job Trends (13241)
News (298593)
Policy (28347)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (8)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (9)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (7)
2024 Genetown Digital (9)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (7)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2701)
Academic (1)
Accelerated approval (6)
Adcomms (27)
Allergies (83)
Alliances (44501)
ALS (90)
Alzheimer's disease (1439)
Antibody-drug conjugate (ADC) (125)
Approvals (15773)
Artificial intelligence (270)
Autoimmune disease (21)
Automation (13)
Bankruptcy (284)
Best Places to Work (11152)
BIOSECURE Act (13)
Biosimilars (96)
Biotechnology (308)
Bladder cancer (65)
Brain cancer (27)
Breast cancer (262)
Cancer (2107)
Cardiovascular disease (174)
Career advice (2102)
Career pathing (31)
CAR-T (151)
Cell therapy (426)
Cervical cancer (21)
Clinical research (62550)
Collaboration (813)
Compensation (384)
Complete response letters (22)
COVID-19 (2637)
CRISPR (42)
C-suite (222)
Cystic fibrosis (101)
Data (2019)
Decentralized trials (2)
Denatured (32)
Depression (48)
Diabetes (244)
Diagnostics (6174)
Digital health (16)
Diversity (8)
Diversity, equity & inclusion (40)
Drug discovery (118)
Drug pricing (94)
Drug shortages (22)
Duchenne muscular dystrophy (92)
Earnings (65296)
Editorial (36)
Employer branding (23)
Employer resources (148)
Events (92886)
Executive appointments (663)
FDA (16927)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (719)
Gene editing (105)
Generative AI (25)
Gene therapy (304)
GLP-1 (694)
Government (4328)
Grass and pollen (5)
Guidances (49)
Healthcare (18578)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (123)
Indications (27)
Infectious disease (2778)
Inflammatory bowel disease (140)
Inflation Reduction Act (10)
Influenza (47)
Intellectual property (87)
Interviews (504)
IPO (14676)
IRA (44)
Job creations (2544)
Job search strategy (1727)
Kidney cancer (10)
Labor market (28)
Layoffs (445)
Leadership (19)
Legal (5566)
Liver cancer (74)
Lung cancer (307)
Lymphoma (130)
Machine learning (4)
Management (60)
Manufacturing (256)
MASH (64)
Medical device (12942)
Medtech (12946)
Mergers & acquisitions (15965)
Metabolic disorders (638)
Multiple sclerosis (78)
NASH (21)
Neurodegenerative disease (101)
Neuropsychiatric disorders (29)
Neuroscience (1974)
NextGen: Class of 2025 (6275)
Non-profit (4513)
Northern California (2349)
Now hiring (25)
Obesity (334)
Opinion (242)
Ovarian cancer (74)
Pain (84)
Pancreatic cancer (77)
Parkinson's disease (147)
Partnered (20)
Patents (200)
Patient recruitment (98)
Peanut (49)
People (51302)
Pharmaceutical (72)
Pharmacy benefit managers (11)
Phase I (19724)
Phase II (27666)
Phase III (20685)
Pipeline (1079)
Podcasts (92)
Policy (115)
Postmarket research (2216)
Preclinical (8359)
Press Release (59)
Prostate cancer (92)
Psychedelics (37)
Radiopharmaceuticals (260)
Rare diseases (387)
Real estate (4334)
Recruiting (69)
Regulatory (20463)
Reports (35)
Research institute (2473)
Resumes & cover letters (410)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (73)
Series A (127)
Series B (81)
Service/supplier (5)
Sickle cell disease (54)
Southern California (2010)
Special edition (16)
Spinal muscular atrophy (156)
Sponsored (32)
Startups (3208)
State (2)
Stomach cancer (15)
Supply chain (53)
Tariffs (13)
The Weekly (58)
United States (20786)
Vaccines (728)
Venture capitalists (35)
Webinars (10)
Weight loss (222)
Women's health (31)
Worklife (19)
Date
Today (59)
Last 7 days (629)
Last 30 days (2428)
Last 365 days (32929)
2025 (8262)
2024 (34830)
2023 (39544)
2022 (50408)
2021 (54375)
2020 (52648)
2019 (44783)
2018 (33706)
2017 (30974)
2016 (29552)
2015 (34064)
2014 (25399)
2013 (20411)
2012 (21669)
2011 (22135)
2010 (20086)
Location
Africa (745)
Alabama (53)
Alaska (6)
Arizona (169)
Arkansas (14)
Asia (35844)
Australia (6436)
California (5369)
Canada (1809)
China (472)
Colorado (237)
Connecticut (253)
Delaware (131)
Europe (82521)
Florida (790)
Georgia (198)
Idaho (55)
Illinois (482)
India (23)
Indiana (297)
Iowa (7)
Japan (140)
Kansas (101)
Kentucky (18)
Louisiana (8)
Maine (69)
Maryland (847)
Massachusetts (4202)
Michigan (198)
Minnesota (345)
Mississippi (2)
Missouri (76)
Montana (31)
Nebraska (21)
Nevada (50)
New Hampshire (68)
New Jersey (1569)
New Mexico (29)
New York (1556)
North Carolina (950)
North Dakota (7)
Northern California (2349)
Ohio (189)
Oklahoma (14)
Oregon (37)
Pennsylvania (1147)
Puerto Rico (10)
Rhode Island (25)
South America (1031)
South Carolina (18)
South Dakota (1)
Southern California (2010)
Tennessee (87)
Texas (813)
Utah (163)
Virginia (135)
Washington D.C. (53)
Washington State (498)
West Virginia (3)
Wisconsin (45)
610,667 Results for "im therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immunome Doses First Patient in Phase 1 Trial of IM-1021, a ROR1-Targeted ADC
March 10, 2025
·
2 min read
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
Press Releases
Prenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements
December 19, 2024
·
2 min read
Deals
Enlyte and Former Genex Leaders Reach Agreement to Create New IME Business
Enlyte and its Board of Directors have made the strategic decision to transfer its Independent Medical Examination (IME) business and more than 350 employees from Enlyte to the creation of a new, stand-alone IME company, Emperion, Inc.
March 5, 2024
·
2 min read
Press Releases
Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
November 18, 2024
·
8 min read
Press Releases
Astellas to Present VEOZA™ (fezolinetant) Data at IMS World Congress on Menopause
October 10, 2024
·
7 min read
Press Releases
Immunome Presents Compelling Preclinical Data Demonstrating Robust Anti-Tumor Activity for IM-1021
October 29, 2024
·
4 min read
BioForest
Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting
Immunome, Inc. today announced that it will present preclinical data for IM-3050, the company’s lead lutetium-177 radioligand therapy (RLT) targeting fibroblast activation protein (FAP).
April 5, 2024
·
5 min read
Press Releases
IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer’s and Weight Loss Therapies
November 7, 2024
·
3 min read
Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA
Theratechnologies Inc today announced that the Company has filed a supplemental Biologics License Application (sBLA) for an intramuscular (IM) method of administration for the maintenance dose of Trogarzo® (ibalizumab-uiyk) to the United States Food and Drug Administration (FDA) for review.
January 2, 2024
·
7 min read
1 of 61,067
Next
